Integrated Diagnostics Holdings
IDHC · Main Market · Health Care · mcap £231m · 39.7p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 11 Sep 26 | Results | Half-year Results
IDH reported 37% revenue growth to EGP 4.9bn in 1H 2026 with 38% EBITDA growth and 47% net profit growth. |
+1.2% |
| 04 Sep 26 | Routine | Notice of Results | |
| 17 Aug 26 | Director dealing | Director/PDMR Shareholding | |
| 13 Aug 26 | Acceptance Level Update
Bidco announces closure of mandatory offer for IDH with 56.67% acceptance including Elliott stake. |
+2.9% | |
| 06 Aug 26 | Acceptance Level Update
Bidco received acceptances for 7.04% of IDH shares by Day 28, holding 56.66% total including Elliott Transaction shares. |
+7.4% | |
| 04 Aug 26 | Director dealing | Director/PDMR Shareholding | |
| 04 Aug 26 | Holding | Holding(s) in Company | |
| 30 Jul 26 | Day 21 Acceptance Level Update
Bidco has received acceptances for 7.04% of IDH shares at Day 21 of mandatory offer. |
−2.7% | |
| 29 Jul 26 | Offer Unconditional
Mandatory offer by Hena Holdings for IDH now unconditional at US$0.50 per share following 56.6% acceptance. |
+9.1% | |
| 28 Jul 26 | Acceptance Level Update
Bidco acquired 49.76% of IDH shares with US$0.50/share offer; 0.14% acceptance from shareholders as of 27 July. |
+1.9% | |
| 27 Jul 26 | Acceptance Level Update
Bidco acquires 49.73% acceptance on mandatory offer at US$0.50 per share; offer remains open until 29 July 2026. |
+1.9% | |
| 24 Jul 26 | Acceptance Level Update
Unrecommended mandatory offer for Integrated Diagnostics at US$0.50 per share has received minimal acceptances at Day 15. |
+0.0% | |
| 23 Jul 26 | Acceptance Level Update
Bidco received no acceptances by day 14 of mandatory 50 cent per share cash offer for IDH. |
+2.3% | |
| 08 Jul 26 | Publication of Offer Document
Unrecommended mandatory cash offer for IDH at US$0.50 per share by Bidco, with offer document published and acceptance deadline 29 July 2026. |
+1.6% | |
| 03 Jul 26 | Routine | Form 8 - Integrated Diagnostics Holdings Plc | |
| 01 Jul 26 | Routine | OPD Rule 8.3 – Integrated Diagnostics Holdings plc | |
| 24 Jun 26 | Holding | Holding(s) in Company | |
| 24 Jun 26 | Routine | Form 8 (OPD) - IDH plc | |
| 23 Jun 26 | Director dealing | Director/PDMR Shareholding | |
| 23 Jun 26 | Holding | Holding(s) in Company | |
| 23 Jun 26 | Statement re Mandatory Final Cash Offer
Hena Holdings launches mandatory cash offer for IDH at USD0.50 per share following 21.67% stake acquisition. |
−11.9% | |
| 23 Jun 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
−11.9% | |
| 23 Jun 26 | Mandatory Final Cash Offer
Hena Holdings announces mandatory cash offer for IDH at $0.50 per share after acquiring 21.67% stake from Elliot. |
−11.9% | |
| 20 May 26 | Results | Replacement - 1st Quarter Results
The following amendment has been made to the announcement released on 20 May 2026 at 07:00:02 under RNS Number 9748E. |
+2.5% |
| 20 May 26 | Results | 1st Quarter Results
Integrated Diagnostics Holdings plc reports 31% revenue growth in Q1 2026 with continued expansion across core markets and resilient profitability performance |
+2.5% |
| 19 May 26 | Routine | Result of AGM | |
| 30 Apr 26 | Routine | Replacement - Holding(s) in Company | |
| 23 Apr 26 | Annual Financial Report & Notice of AGM
Annual Financial Report & Notice of Annual General Meeting |
+0.3% | |
| 17 Apr 26 | Results | Final Results
Integrated Diagnostics Holdings plc delivers 37% revenue growth in FY 2025 with strong margin expansion and bottom-line performance |
−1.9% |
| 08 Apr 26 | Holding | Holding(s) in Company | |
| 08 Apr 26 | Holding | Holding(s) in Company | |
| 13 Nov 25 | Results | 3rd Quarter Results
Integrated Diagnostics Holdings plc delivers 41% revenue growth in 9M 2025 with continued margin expansion and robust bottom-line performance |
+20.9% |
| 07 Nov 25 | Routine | Notice of Results |
Company filings. Not investment advice.